Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ... OSA and obesity. After taking tirzepatide (Zepbound) for a year, these ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Those who took Zepbound also lost more weight than the placebo group after one year. Their symptom improvement was likely thanks to their weight loss, the FDA said. Zepbound is a glucagon-like ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.